Should you buy Merck & Co. stock? (NYSE:MRK). Let's see how it does in our automated value investing analysis system.
Based on historical returns, we believe that Merck & Co. can grow its free cash at a rate of about 8%. That's positive!
(Merck & Co. stock price per share)
||MRK Fair Price
(based on intrinsic value)
||MRK Safety Price (based on a variable margin of safety)||$57.45|
||PE Ratio versus Sector||226% higher than other Healthcare stocks|
|PE Ratio versus Industry||284% higher than other Drug Manufacturers - Major stocks|
|Free Cash Flow Jitter||27%|
We believe that Merck & Co. may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
Merck & Co. looks like a price in the fair value range. Based on our analysis—if the company keeps making money the way it has been—you could be looking at a good stock. See Before You Buy for your next steps.
Does Merck & Co. have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles